Orally administered corticosteroid compositions
AssigneeAdare Pharmaceuticals, Inc.
InventorsStephen Perrett, Fredric Jay Cohen, Gopi Venkatesh
Life of this patent
Estimating the term…
Abstract
The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
Claims21
An oral, liquid pharmaceutical composition comprising budesonide, a pharmaceutically acceptable liquid, and a phase change agent dissolved or suspended in the pharmaceutically acceptable liquid, wherein after oral administration to a patient, said composition undergoes a change in physical properties of the composition upon contact with the upper gastrointestinal tract of said patient, whereby contact of the corticosteroid with the upper gastrointestinal tract of the patient is enhanced and/or prolonged.
Dependencies are inferred from the claim text.